| Title |
How Successful is Switching from Bevacizumab or Ranibizumab to Aflibercept in Age-Related Macular Degeneration? A Systematic Overview
|
|---|---|
| Published in |
Advances in Therapy, May 2019
|
| DOI | 10.1007/s12325-019-00971-0 |
| Pubmed ID | |
| Authors |
Theodoros Empeslidis, Matthew Storey, Theodoros Giannopoulos, Vassileios Konidaris, Paris G. Tranos, Evangelia S. Panagiotou, Irini C. Voudouragkaki, Anastasios G. Konstas |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 3 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 67% |
| Science communicators (journalists, bloggers, editors) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 35 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 35 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Postgraduate | 4 | 11% |
| Student > Master | 3 | 9% |
| Student > Bachelor | 2 | 6% |
| Researcher | 2 | 6% |
| Lecturer > Senior Lecturer | 1 | 3% |
| Other | 3 | 9% |
| Unknown | 20 | 57% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 10 | 29% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 9% |
| Nursing and Health Professions | 2 | 6% |
| Unknown | 20 | 57% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 May 2019.
All research outputs
#14,916,971
of 23,148,322 outputs
Outputs from Advances in Therapy
#1,235
of 2,388 outputs
Outputs of similar age
#203,293
of 351,547 outputs
Outputs of similar age from Advances in Therapy
#37
of 58 outputs
Altmetric has tracked 23,148,322 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,388 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.4. This one is in the 46th percentile – i.e., 46% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 351,547 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 58 others from the same source and published within six weeks on either side of this one. This one is in the 36th percentile – i.e., 36% of its contemporaries scored the same or lower than it.